Contractile recovery of heart muscle after hypothermic hypoxia is improved by nicorandil via mitochondrial KATP channels

European Journal of Cardio-thoracic Surgery

Volumn 30, Issue 2, 2006, Pages 256-262

  Steensrud, Tor ^a   Jakobsen, Øyvind ^a   Ytrehus, Kirsti ^b   Sørlie, Dag G ^a  

^a UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^b UNIVERSITY OF TROMSØ   (Norway)

Author keywords

Cardioplegia; Hypothermia; Hypoxia

Indexed keywords

5 HYDROXYDECANOIC ACID; ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; CLAMIKALANT; GLUCOSE; NICORANDIL;

ANIMAL TISSUE; ARTICLE; CARDIOPLEGIA; CONCENTRATION RESPONSE; CONTROLLED STUDY; CONVALESCENCE; DEPLETION; DRUG EFFECT; DRUG MECHANISM; EX VIVO STUDY; GUINEA PIG; HEART MITOCHONDRION; HEART MUSCLE CONTRACTILE FORCE; HEART MUSCLE CONTRACTILITY; HEART MUSCLE ISCHEMIA; HEART MUSCLE POTENTIAL; HEART PAPILLARY MUSCLE; HEART PROTECTION; HYPOTHERMIA; NONHUMAN; PRIORITY JOURNAL; REOXYGENATION; SARCOLEMMA; TEMPERATURE DEPENDENCE;

ACTION POTENTIALS; ANIMALS; ANOXIA; CARDIOTONIC AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; GUINEA PIGS; HEART; HEART ARREST, INDUCED; HYPOTHERMIA, INDUCED; MITOCHONDRIA, HEART; MYOCARDIAL CONTRACTION; NICORANDIL; POTASSIUM CHANNELS; TEMPERATURE; TISSUE CULTURE TECHNIQUES; VASODILATOR AGENTS;

EID: 33745900219     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2006.04.033     Document Type: Article

References (25)

1. Bjornstad H., Tande P.M., and Refsum H. Class III antiarrhythmic action of d-sotalol during hypothermia. Am Heart J 121 (1991) 1429-1436
2. Gross G.J., Auchampach J.A., Maruyama M., Warltier D.C., and Pieper G.M. Cardioprotective effects of nicorandil. J Cardiovasc Pharmacol 20 Suppl. 3 (1992) S22-S28
3. Hayashi Y., Sawa Y., Ohtake S., Nishimura M., Ichikawa H., and Matsuda H. Controlled nicorandil administration for myocardial protection during coronary artery bypass grafting under cardiopulmonary bypass. J Cardiovasc Pharmacol 38 (2001) 21-28
4. Li Y., Iguchi A., Tsuru Y., Nakame T., Satou K., and Tabayashi K. Nicorandil pretreatment and improved myocardial protection during cold blood cardioplegia. Jpn J Thorac Cardiovasc Surg 48 (2000) 24-29
5. Lathrop D.A., Contney S.J., Bosnjak Z.J., and Stowe D.F. Reversal of hypothermia-induced action potential lengthening by the KATP channel agonist bimakalim in isolated guinea pig ventricular muscle. Gen Pharmacol 31 (1998) 125-131
6. Paucek P., Mironova G., Mahdi F., Beavis A.D., Woldegiorgis G., and Garlid K.D. Reconstitution and partial purification of the glibenclamide-sensitive, ATP-dependent K+ channel from rat liver and beef heart mitochondria. J Biol Chem 267 (1992) 26062-26069
7. Gross G.J. The role of mitochondrial KATP channels in cardioprotection. Basic Res Cardiol 95 (2000) 280-284
8. Yao Z., and Gross G.J. Effects of the KATP channel opener bimakalim on coronary blood flow, monophasic action potential duration, and infarct size in dogs. Circulation 89 (1994) 1769-1775
9. Grover G.J., D'Alonzo A.J., Parham C.S., and Darbenzio R.B. Cardioprotection with the KATP opener cromakalim is not correlated with ischemic myocardial action potential duration. J Cardiovasc Pharmacol 26 (1995) 145-152
10. Garlid K.D., Paucek P., Yarov-Yarovoy V., Murray H.N., Darbenzio R.B., D'Alonzo A.J., Lodge N.J., Smith M.A., and Grover G.J. Cardioprotective effect of diazoxide and its interaction with mitochondrial ATP-sensitive K+ channels. Possible mechanism of cardioprotection. Circ Res 81 (1997) 1072-1082
11. Sato T., Sasaki N., O'Rourke B., and Marban E. Nicorandil, a potent cardioprotective agent, acts by opening mitochondrial ATP-dependent potassium channels. J Am Coll Cardiol 35 (2000) 514-518
12. Tsuchida A., Miura T., Tanno M., Sakamoto J., Miki T., Kuno A., Matsumoto T., Ohnuma Y., Ichikawa Y., and Shimamoto K. Infarct size limitation by nicorandil: roles of mitochondrial K(ATP) channels, sarcolemmal K(ATP) channels, and protein kinase C. J Am Coll Cardiol 40 (2002) 1523-1530
13. Taira N. Similarity and dissimilarity in the mode and mechanism of action between nicorandil and classical nitrates: an overview. J Cardiovasc Pharmacol 10 Suppl. 8 (1987) S1-S9
14. Steensrud T., Nordhaug D., Elvenes O.P., Korvald C., and Sorlie D.G. Superior myocardial protection with nicorandil cardioplegia. Eur J Cardiothorac Surg 23 (2003) 670-677
15. Jaburek M., Yarov-Yarovoy V., Paucek P., and Garlid K.D. State-dependent inhibition of the mitochondrial KATP channel by glyburide and 5-hydroxydecanoate. J Biol Chem 273 (1998) 13578-13582
16. Davie C.S., Kubo M., and Standen N.B. Potassium channel activation and relaxation by nicorandil in rat small mesenteric arteries. Br J Pharmacol 125 (1998) 1715-1725
17. Menasche P., Mouas C., and Grousset C. Is potassium channel opening an effective form of preconditioning before cardioplegia?. Ann Thorac Surg 61 (1996) 1764-1768
18. Suzuki M., Saito T., Sato T., Tamagawa M., Miki T., Seino S., and Nakaya H. Cardioprotective effect of diazoxide is mediated by activation of sarcolemmal but not mitochondrial ATP-sensitive potassium channels in mice. Circulation 107 (2003) 682-685
19. Rodrigo G.C., Davies N.W., and Standen N.B. Diazoxide causes early activation of cardiac sarcolemmal KATP channels during metabolic inhibition by an indirect mechanism. Cardiovasc Res 61 (2004) 570-579
20. Kajioka S., Oike M., and Kitamura K. Nicorandil opens a calcium-dependent potassium channel in smooth muscle cells of the rat portal vein. J Pharmacol Exp Ther 254 (1990) 905-913
21. Juhaszova M., Zorov D.B., Kim S.H., Pepe S., Fu Q., Fishbein K.W., Ziman B.D., Wang S., Ytrehus K., Antos C.L., Olson E.N., and Sollott S.J. Glycogen synthase kinase-3beta mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore. J Clin Invest 113 (2004) 1535-1549
22. Sugimoto S., Iwashiro K., Monti F., Dawodu A.A., Schiariti M., and Puddu P.E. The risk of myocardial stunning is decreased concentration-dependently by KATP channel activation with nicorandil before high K+ cardioplegia. Int J Cardiol 48 (1995) 11-25
23. Tiritilli A. Guanylate cyclase and not ATP-dependent K(+) channels seems temperature-dependent in smooth muscle relaxation of human umbilical arteries. Eur J Pharmacol 406 (2000) 79-84
24. Grover G.J., and Garlid K.D. ATP-sensitive potassium channels: a review of their cardioprotective pharmacology. J Mol Cell Cardiol 32 (2000) 677-695
25. Galinanes M., Shattock M.J., and Hearse D.J. Effects of potassium channel modulation during global ischaemia in isolated rat heart with and without cardioplegia. Cardiovasc Res 26 (1992) 1063-1068